ghk-cu lyophilized GHK-Cu (100MG) LYOPHILIZED – TENNESSEE

Following these principles preserves peptide integrity and ensures consistent research results

Composition GHK-Cu: 50 mg KPV: 10 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of four co-formulated peptides Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability

Not everyone faces the same cancer risk, and personal circumstances should guide the approach to any substance with theoretical oncological concerns

Dihexa Dihexa, an oligopeptide drug, is an orally active and blood-brain barrier-permeable angiotensin IV analog